STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in slowing prostate cancer spread
Disease control CompletedThis study looked at whether adding the drug axitinib to standard hormone therapy before surgery could help control prostate cancer that has spread to lymph nodes. 73 men with previously untreated prostate cancer took part. The goal was to see if the combination could delay cance…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New combo therapy shows promise for hard-to-treat prostate cancer
Disease control CompletedThis study tested whether adding targeted radiation to a hormone-blocking drug (apalutamide) helps control prostate cancer that has stopped responding to standard hormone therapy and spread to a few spots. Twenty-six men with castration-resistant prostate cancer took part. The ma…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 13:50 UTC